SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001370053-22-000064
Filing Date
2022-11-08
Accepted
2022-11-08 16:08:53
Documents
48
Period of Report
2022-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K anab-20221108.htm   iXBRL 8-K 34349
2 EX-99.1 q32022earningsrelease.htm EX-99.1 99570
3 EX-99.2 anabcorporateoverviewnov.htm EX-99.2 40641
8 anabcorporateoverviewnov001.jpg GRAPHIC 58418
9 anabcorporateoverviewnov002.jpg GRAPHIC 228176
10 anabcorporateoverviewnov003.jpg GRAPHIC 195056
11 anabcorporateoverviewnov004.jpg GRAPHIC 134576
12 anabcorporateoverviewnov005.jpg GRAPHIC 57843
13 anabcorporateoverviewnov006.jpg GRAPHIC 126550
14 anabcorporateoverviewnov007.jpg GRAPHIC 141496
15 anabcorporateoverviewnov008.jpg GRAPHIC 151859
16 anabcorporateoverviewnov009.jpg GRAPHIC 69109
17 anabcorporateoverviewnov010.jpg GRAPHIC 121682
18 anabcorporateoverviewnov011.jpg GRAPHIC 142916
19 anabcorporateoverviewnov012.jpg GRAPHIC 142241
20 anabcorporateoverviewnov013.jpg GRAPHIC 119724
21 anabcorporateoverviewnov014.jpg GRAPHIC 175861
22 anabcorporateoverviewnov015.jpg GRAPHIC 130197
23 anabcorporateoverviewnov016.jpg GRAPHIC 169742
24 anabcorporateoverviewnov017.jpg GRAPHIC 134080
25 anabcorporateoverviewnov018.jpg GRAPHIC 166101
26 anabcorporateoverviewnov019.jpg GRAPHIC 153950
27 anabcorporateoverviewnov020.jpg GRAPHIC 152859
28 anabcorporateoverviewnov021.jpg GRAPHIC 179341
29 anabcorporateoverviewnov022.jpg GRAPHIC 57134
30 anabcorporateoverviewnov023.jpg GRAPHIC 142859
31 anabcorporateoverviewnov024.jpg GRAPHIC 173772
32 anabcorporateoverviewnov025.jpg GRAPHIC 57320
33 anabcorporateoverviewnov026.jpg GRAPHIC 159044
34 anabcorporateoverviewnov027.jpg GRAPHIC 117453
35 anabcorporateoverviewnov028.jpg GRAPHIC 172024
36 anabcorporateoverviewnov029.jpg GRAPHIC 175491
37 anabcorporateoverviewnov030.jpg GRAPHIC 77934
38 anabcorporateoverviewnov031.jpg GRAPHIC 174101
39 anabcorporateoverviewnov032.jpg GRAPHIC 191259
40 anabcorporateoverviewnov033.jpg GRAPHIC 43474
  Complete submission text file 0001370053-22-000064.txt   6572585

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anab-20221108.xsd EX-101.SCH 2175
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anab-20221108_def.xml EX-101.DEF 8981
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anab-20221108_lab.xml EX-101.LAB 33134
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anab-20221108_pre.xml EX-101.PRE 20654
42 EXTRACTED XBRL INSTANCE DOCUMENT anab-20221108_htm.xml XML 10999
Mailing Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Filer) CIK: 0001370053 (see all company filings)

IRS No.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37985 | Film No.: 221368942
SIC: 2834 Pharmaceutical Preparations